Research ArticleOriginal Research

Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW

Stephan R. Lindner, Bijal Balasubramanian, Miguel Marino, K. John McConnell, Thomas E. Kottke, Samuel T. Edwards, Sam Cykert and Deborah J. Cohen
The Journal of the American Board of Family Medicine May 2023, 36 (3) 462-476; DOI: https://doi.org/10.3122/jabfm.2022.220331R1

References

  1. ↵
    1. Benjamin EJ,
    2. Muntner P,
    3. Alonso A
    , On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommitteeet al. Heart disease and stroke statistics-2019 update: A report from the American Heart Association. Circulation 2019;139:e56–e528.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Lloyd-Jones DM,
    2. Huffman MD,
    3. Karmali KN,
    4. et al
    . Estimating longitudinal risks and benefits from cardiovascular preventive therapies among Medicare patients. Journal of the American College of Cardiology 2017;69:1617–36.
    OpenUrlFREE Full Text
  3. ↵
    1. Karmali KN,
    2. Lloyd-Jones DM,
    3. Berendsen MA,
    4. et al
    . Drugs for primary prevention of atherosclerotic cardiovascular disease. JAMA Cardiol 2016;1:341–9.
    OpenUrl
  4. ↵
    1. Farley TA,
    2. Dalal MA,
    3. Mostashari F,
    4. Frieden TR
    . Deaths preventable in the U.S. by improvements in use of clinical preventive services. American Journal of Preventive Medicine 2010;38:600–9.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Frieden TR,
    2. Berwick DM
    . The “million hearts” initiative - preventing heart attacks and strokes. N Engl J Med 2011;365:e27.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Hing E,
    2. Rui P,
    3. Palso K
    . National ambulatory medical care survey: 2013 state and national summary tables. 2013. Available at: https://www.cdc.gov/nchs/data/ahcd/namcs_summary/2013_namcs_web_tables.pdf.
  7. ↵
    1. Cohen DJ,
    2. Dorr DA,
    3. Knierim K,
    4. et al
    . Primary care practices’ abilities and challenges in using electronic health record data for quality improvement. Health Affairs 2018;37:635–43.
    OpenUrlCrossRef
  8. ↵
    1. Cohen DJ,
    2. Balasubramanian BA,
    3. Gordon L,
    4. et al
    . A national evaluation of a dissemination and implementation initiative to enhance primary care practice capacity and improve cardiovascular disease care: The Escalates study protocol. Implementation Sci 2015;11:86.
    OpenUrl
  9. ↵
    1. Balasubramanian BA,
    2. Lindner S,
    3. Marino M,
    4. et al
    . Improving delivery of cardiovascular disease preventive services in small-to-medium primary care practices. J Am Board Fam Med 2022.
  10. ↵
    1. Persell SD,
    2. Liss DT,
    3. Walunas TL,
    4. et al
    . Effects of 2 forms of practice facilitation on cardiovascular prevention in primary care. Med Care 2020;58:344–51.
    OpenUrl
  11. ↵
    1. Cykert S,
    2. Keyserling TC,
    3. Pignone M,
    4. et al
    . A controlled trial of dissemination and implementation of a cardiovascular risk reduction strategy in small primary care practices. Health Serv Res 2020;55:944–53.
    OpenUrlCrossRef
  12. ↵
    1. Parchman ML,
    2. Anderson ML,
    3. Dorr DA,
    4. et al
    . A randomized trial of external practice support to improve cardiovascular risk factors in primary care. Ann Fam Med 2019;17:S40–S49.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Shelley DR,
    2. Gepts T,
    3. Siman N,
    4. et al
    . Cardiovascular disease guideline adherence: An RCT using practice facilitation. American Journal of Preventive Medicine 2020;58:683–90.
    OpenUrl
  14. ↵
    1. Dickinson WP,
    2. Nease DE,
    3. Rhyne RL,
    4. et al
    . Practice transformation support and patient engagement to improve cardiovascular care: From EvidenceNOW Southwest (ENSW). J Am Board Fam Med 2020;33:675–86.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Goff DC,
    2. Lloyd-Jones DM,
    3. Bennett G
    , American College of Cardiology/American Heart Association Task Force on Practice Guidelineset al. 2013 acc/aha guideline on the assessment of cardiovascular risk. Circulation 2014;129:S49–73.
    OpenUrlFREE Full Text
  16. ↵
    1. Balasubramanian BA,
    2. Marino M,
    3. Cohen DJ,
    4. et al
    . Use of quality improvement strategies among small to medium-size us primary care practices. Ann Fam Med 2018;16:S35–S43.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Lindner S,
    2. Solberg L,
    3. Miller W,
    4. et al
    . Does ownership make a difference in primary care practice? J Am Board Fam Med 2019;32:398–407.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Muntner P,
    2. Colantonio LD,
    3. Cushman M,
    4. et al
    . Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations. JAMA 2014;311:1406–15.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Collaboration.
    AT Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71–86.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Cummings SR
    . The cost-effectiveness of counseling smokers to quit. JAMA 1989;261:75.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    Tobacco use and dependence guideline panel. Treating tobacco use and dependence: 2008 update. US Department of Health; Human Services; 2008.
  22. ↵
    1. Wray JM,
    2. Funderburk JS,
    3. Acker JD,
    4. Wray LO,
    5. Maisto SA
    . A meta-analysis of brief tobacco interventions for use in integrated primary care. Nicotine & Tobacco Research 2018;20:1418–26.
    OpenUrlPubMed
  23. ↵
    1. Bonafede M,
    2. Johnson B,
    3. Gandra S,
    4. Richhariya A
    . Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia. ClinicoEconomics and Outcomes Research 2015;7:337–45.
    OpenUrl
  24. ↵
    1. Cohen DJ,
    2. Balasubramanian BA,
    3. Lindner S,
    4. et al
    . How does prior experience pay off in large-scale quality improvement initiatives? The J Am Board Fam Med 2022;35:1115–27.
    OpenUrl
  25. ↵
    1. Chambers LW,
    2. Kaczorowski J,
    3. Dolovich L,
    4. et al
    . A community-based program for cardiovascular health awareness. Canadian Journal of Public Health 2005;96:294–8.
    OpenUrlPubMedWeb of Science
  26. ↵
    1. Kaczorowski J,
    2. Chambers LW,
    3. Karwalajtys T,
    4. et al
    . Cardiovascular health awareness program (CHAP): A community cluster-randomised trial among elderly Canadians. Preventive Medicine 2008;46:537–44.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Kaczorowski J,
    2. Chambers LW,
    3. Dolovich L,
    4. et al
    . Improving cardiovascular health at population level: 39 community cluster randomised trial of cardiovascular health awareness program (CHAP). BMJ 2011;342:d442–2.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Goeree RKC,
    2. von Burke N,
    3. et al
    . Economic appraisal of a community-wide cardiovascular health awareness program. Value in Health 2013;16:39–45.
    OpenUrl
  29. ↵
    1. Muntner P,
    2. Hardy ST,
    3. Fine LJ,
    4. et al
    . Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA 2020;324:1190.
    OpenUrlPubMed
  30. ↵
    1. Yao X,
    2. Shah ND,
    3. Gersh BJ,
    4. Lopez-Jimenez F,
    5. Noseworthy PA
    . Assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016. JAMA Network Open 2020;3:e2025505–5.
    OpenUrl
  31. ↵
    1. Salami JA,
    2. Warraich H,
    3. Valero-Elizondo J,
    4. et al
    . National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the Medical Expenditure Panel Survey. JAMA Cardiology 2017;2:56–65.
    OpenUrl
  32. ↵
    1. Cohen DJ,
    2. Sweeney SM,
    3. Miller WL,
    4. et al
    . Improving smoking and blood pressure outcomes: The interplay between operational changes and local context. Ann Fam Med 2021;19:240–8.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Rose G
    . Strategy of prevention: Lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981;282:1847–51.
    OpenUrlFREE Full Text
  34. ↵
    1. Kadakia KT,
    2. Song Z
    . Saving money or improving health? Reconsidering payment reform. Milbank Quarterly Opinion 2022.
  35. ↵
    1. Ono SS,
    2. Crabtree BF,
    3. Hemler JR,
    4. et al
    . Taking innovation to scale in primary care practices: the functions of health care extension. Health Affairs 2018;37:222–30.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Sweeney SM,
    2. Hemler JR,
    3. Baron AN,
    4. et al
    . Dedicated workforce required to support large-scale practice improvement. The J Am Board Fam Med 2020;33:230–9.
    OpenUrl
  37. ↵
    1. Marino M,
    2. Solberg L,
    3. Springer R,
    4. et al
    . Cardiovascular disease preventive services among smaller primary care practices. American Journal of Preventive Medicine 2021.
  38. ↵
    1. Perry CK,
    2. Lindner S,
    3. Hall J,
    4. Solberg LI,
    5. Baron A,
    6. Cohen DJ
    . How type of practice ownership affects participation with quality improvement external facilitation: findings from EvidenceNOW. Journal of General Internal Medicine 2022;37:793–801.
    OpenUrl
  39. ↵
    1. Sweeney SM,
    2. Baron A,
    3. Hall JD,
    4. et al
    . Effective facilitator strategies for supporting primary care practice change: a mixed methods study. Ann Fam Med 2022;20:414–22.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords